Tools & Documentations

Our publications

Since its creation, Institut Roche has translated its expertise into numerous successful scientific publications

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3. The European respiratory journal, 39(1), 172–179.

Borget, I., Cadranel, J., Pignon, J. P., Quoix, E., Coudert, B., Westeel, V., Dansin, E., Madelaine, J., Madroszyk, A., Friard, S., Daniel, C., Morin, F., Chouaid, C., & ERMETIC Collaborative Group (2012).

https://doi.org/10.1183/09031936.00201210

ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 22(3), 575–581.

Besse, B., Massard, C., Haddad, V., Andre, F., Dunant, A., Pirker, R., Olaussen, K. A., Brambilla, E., Fouret, P., & Soria, J. C. (2011).

https://doi.org/10.1093/annonc/mdq407